• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 CRISPR 激活靶向转录上调 SENP1,增强去 SUMOylation 途径,在神经病理性疼痛的脊神经结扎模型中产生镇痛作用。

Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.

机构信息

Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, United States.

NYU Pain Research Center, New York, NY, United States.

出版信息

Pain. 2024 Apr 1;165(4):866-883. doi: 10.1097/j.pain.0000000000003080. Epub 2023 Oct 20.

DOI:10.1097/j.pain.0000000000003080
PMID:37862053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11389604/
Abstract

The voltage-gated sodium channel Na V 1.7 is an essential component of human pain signaling. Changes in Na V 1.7 trafficking are considered critical in the development of neuropathic pain. SUMOylation of collapsin response mediator protein 2 (CRMP2) regulates the membrane trafficking and function of Na V 1.7. Enhanced CRMP2 SUMOylation in neuropathic pain correlates with increased Na V 1.7 activity. Pharmacological and genetic interventions that interfere with CRMP2 SUMOylation in rodents with neuropathic pain have been shown to reverse mechanical allodynia. Sentrin or SUMO-specific proteases (SENPs) are vital for balancing SUMOylation and deSUMOylation of substrates. Overexpression of SENP1 and/or SENP2 in CRMP2-expressing cells results in increased deSUMOylation and decreased membrane expression and currents of Na V 1.7. Although SENP1 is present in the spinal cord and dorsal root ganglia, its role in regulating Na V 1.7 function and pain is not known. We hypothesized that favoring SENP1 expression can enhance CRMP2 deSUMOylation to modulate Na V 1.7 channels. In this study, we used a clustered regularly interspaced short palindromic repeats activation (CRISPRa) SENP1 lentivirus to overexpress SENP1 in dorsal root ganglia neurons. We found that SENP1 lentivirus reduced CRMP2 SUMOylation, Na V 1.7-CRMP2 interaction, and Na V 1.7 membrane expression. SENP1 overexpression decreased Na V 1.7 currents through clathrin-mediated endocytosis, directly linked to CRMP2 deSUMOylation. Moreover, enhancing SENP1 expression did not affect the activity of TRPV1 channels or voltage-gated calcium and potassium channels. Intrathecal injection of CRISPRa SENP1 lentivirus reversed mechanical allodynia in male and female rats with spinal nerve injury. These results provide evidence that the pain-regulating effects of SENP1 overexpression involve, in part, the modulation of Na V 1.7 channels through the indirect mechanism of CRMP2 deSUMOylation.

摘要

电压门控钠离子通道 NaV1.7 是人类疼痛信号传导的重要组成部分。NaV1.7 运输的变化被认为是神经性疼痛发展的关键。 collapsin 反应介体蛋白 2 (CRMP2) 的 SUMO 化调节 NaV1.7 的膜运输和功能。神经病理性疼痛中增强的 CRMP2 SUMO 化与 NaV1.7 活性增加相关。在患有神经病理性疼痛的啮齿动物中,干扰 CRMP2 SUMO 化的药理学和遗传学干预已被证明可以逆转机械性痛觉过敏。Sentrin 或 SUMO 特异性蛋白酶 (SENP) 对于平衡底物的 SUMO 化和去 SUMO 化至关重要。在表达 CRMP2 的细胞中过表达 SENP1 和/或 SENP2 会导致去 SUMO 化增加,膜表达和 NaV1.7 电流减少。尽管 SENP1 存在于脊髓和背根神经节中,但它在调节 NaV1.7 功能和疼痛中的作用尚不清楚。我们假设促进 SENP1 表达可以增强 CRMP2 的去 SUMO 化作用,从而调节 NaV1.7 通道。在这项研究中,我们使用聚类规则间隔短回文重复激活 (CRISPRa) SENP1 慢病毒在背根神经节神经元中过表达 SENP1。我们发现 SENP1 慢病毒减少了 CRMP2 SUMO 化、NaV1.7-CRMP2 相互作用和 NaV1.7 膜表达。SENP1 过表达通过网格蛋白介导的内吞作用降低了 NaV1.7 电流,这与 CRMP2 的去 SUMO 化直接相关。此外,增强 SENP1 表达不会影响 TRPV1 通道或电压门控钙和钾通道的活性。鞘内注射 CRISPRa SENP1 慢病毒逆转了脊髓神经损伤雄性和雌性大鼠的机械性痛觉过敏。这些结果提供了证据,表明 SENP1 过表达的疼痛调节作用部分涉及通过 CRMP2 去 SUMO 化的间接机制调节 NaV1.7 通道。

相似文献

1
Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.通过 CRISPR 激活靶向转录上调 SENP1,增强去 SUMOylation 途径,在神经病理性疼痛的脊神经结扎模型中产生镇痛作用。
Pain. 2024 Apr 1;165(4):866-883. doi: 10.1097/j.pain.0000000000003080. Epub 2023 Oct 20.
2
CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.CRMP2 蛋白 SUMOylation 调节 NaV1.7 通道运输。
J Biol Chem. 2013 Aug 23;288(34):24316-31. doi: 10.1074/jbc.M113.474924. Epub 2013 Jul 8.
3
Intranasal CRMP2-Ubc9 inhibitor regulates Na V 1.7 to alleviate trigeminal neuropathic pain.鼻内 CRMP2-Ubc9 抑制剂调节 NaV1.7 缓解三叉神经病理性疼痛。
Pain. 2024 Mar 1;165(3):573-588. doi: 10.1097/j.pain.0000000000003053. Epub 2023 Sep 26.
4
Non-SUMOylated CRMP2 decreases Na1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15.非 SUMO 化的 CRMP2 通过内吞蛋白 NUMB、Nedd4-2 和 Eps15 减少 Na1.7 电流。
Mol Brain. 2021 Jan 21;14(1):20. doi: 10.1186/s13041-020-00714-1.
5
Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.抑制 Ubc9 E2 SUMO 连接酶-CRMP2 相互作用可减少 Nav1.7 电流并逆转实验性神经病理性疼痛。
Pain. 2018 Oct;159(10):2115-2127. doi: 10.1097/j.pain.0000000000001294.
6
Intranasal CRMP2-Ubc9 Inhibitor Regulates Na 1.7 to Alleviate Trigeminal Neuropathic Pain.鼻内注射CRMP2-Ubc9抑制剂通过调节Nav1.7减轻三叉神经病理性疼痛
bioRxiv. 2023 Jul 17:2023.07.16.549195. doi: 10.1101/2023.07.16.549195.
7
Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain.通过抑制CRMP2-Ubc9相互作用靶向NaV1.7的小分子可减轻并预防奥沙利铂诱导的神经性疼痛小鼠模型中的疼痛慢性化。
Neurobiol Pain. 2021 Dec 27;11:100082. doi: 10.1016/j.ynpai.2021.100082. eCollection 2022 Jan-Jul.
8
TNF-α mediated upregulation of Na1.7 currents in rat dorsal root ganglion neurons is independent of CRMP2 SUMOylation.TNF-α 通过上调大鼠背根神经节神经元中的 Na1.7 电流而发挥作用,与 CRMP2 SUMO 化无关。
Mol Brain. 2019 Dec 30;12(1):117. doi: 10.1186/s13041-019-0538-0.
9
SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons.SUMOylation 改变了 CRMP2 对感觉神经元中钙内流的调节。
Channels (Austin). 2013 May-Jun;7(3):153-9. doi: 10.4161/chan.24224. Epub 2013 Mar 19.
10
Conditional knockout of CRMP2 in neurons, but not astrocytes, disrupts spinal nociceptive neurotransmission to control the initiation and maintenance of chronic neuropathic pain.神经元条件性敲除 CRMP2 ,而非星形胶质细胞,破坏了脊髓伤害性神经传递以控制慢性神经性疼痛的起始和维持。
Pain. 2022 Feb 1;163(2):e368-e381. doi: 10.1097/j.pain.0000000000002344.

引用本文的文献

1
SUMO Regulation of Ion Channels in Health and Disease.健康与疾病中离子通道的SUMO调节
Physiology (Bethesda). 2025 Mar 1;40(2):0. doi: 10.1152/physiol.00034.2024. Epub 2024 Nov 5.
2
Dock4 contributes to neuropathic pain by regulating spinal synaptic plasticity in mice.Dock4通过调节小鼠脊髓突触可塑性导致神经性疼痛。
Front Mol Neurosci. 2024 Aug 30;17:1417567. doi: 10.3389/fnmol.2024.1417567. eCollection 2024.
3
SUMOylation and DeSUMOylation: Tug of War of Pain Signaling.小泛素样修饰与去小泛素样修饰:疼痛信号的拉锯战

本文引用的文献

1
Deep RNA-seq of male and female murine sensory neuron subtypes after nerve injury.神经损伤后雄性和雌性小鼠感觉神经元亚型的深度 RNA-seq。
Pain. 2023 Oct 1;164(10):2196-2215. doi: 10.1097/j.pain.0000000000002934. Epub 2023 Jun 6.
2
Structural Basis for the SUMO2 Isoform Specificity of SENP7.SENP7 的 SUMO2 同种型特异性的结构基础。
J Mol Biol. 2022 Dec 30;434(24):167875. doi: 10.1016/j.jmb.2022.167875. Epub 2022 Nov 2.
3
The natural product argentatin C attenuates postoperative pain via inhibition of voltage-gated sodium and T-type voltage-gated calcium channels.
Mol Neurobiol. 2025 Mar;62(3):3305-3321. doi: 10.1007/s12035-024-04478-w. Epub 2024 Sep 14.
4
Crosstalk between PKA and PIAS3 regulates cardiac Kv4 channel SUMOylation.PKA 和 PIAS3 之间的串扰调节心脏 Kv4 通道 SUMOylation。
Cell Commun Signal. 2024 Sep 2;22(1):422. doi: 10.1186/s12964-024-01795-4.
5
Mouse models of non-dystrophic and dystrophic myotonia exhibit nociplastic pain-like behaviors.非营养不良性和营养不良性肌强直的小鼠模型表现出类神经可塑性疼痛行为。
bioRxiv. 2024 Jun 22:2024.06.19.599732. doi: 10.1101/2024.06.19.599732.
6
Pathology of pain and its implications for therapeutic interventions.疼痛的病理学及其对治疗干预的影响。
Signal Transduct Target Ther. 2024 Jun 8;9(1):155. doi: 10.1038/s41392-024-01845-w.
天然产物阿根廷菌素C通过抑制电压门控性钠通道和T型电压门控性钙通道减轻术后疼痛。
Br J Pharmacol. 2023 May;180(9):1267-1285. doi: 10.1111/bph.15974. Epub 2023 Jan 15.
4
Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons.通过 CRISPRa 重编程星形胶质细胞为 GABA 能神经元来拯救帕金森病运动症状。
EMBO Mol Med. 2022 May 9;14(5):e14797. doi: 10.15252/emmm.202114797. Epub 2022 Apr 4.
5
Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications.也许你能激发我的兴趣:CRISPRa 为基础的治疗应用策略。
Cell Mol Life Sci. 2022 Feb 12;79(2):130. doi: 10.1007/s00018-022-04175-8.
6
Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents.通过抑制 CRMP2-Ubc9 相互作用选择性靶向 NaV1.7 可减少啮齿动物的疼痛。
Sci Transl Med. 2021 Nov 10;13(619):eabh1314. doi: 10.1126/scitranslmed.abh1314.
7
The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels.SUMO 特异性蛋白酶 SENP2 在 Kv7.2 和 Kv7.3 钾通道的调节中发挥重要作用。
J Biol Chem. 2021 Oct;297(4):101183. doi: 10.1016/j.jbc.2021.101183. Epub 2021 Sep 10.
8
Depletion of SENP1-mediated PPARγ SUMOylation exaggerates intermittent hypoxia-induced cognitive decline by aggravating microglia-mediated neuroinflammation.SENP1 介导的 PPARγ SUMOylation 耗竭通过加重小胶质细胞介导的神经炎症加剧间歇性低氧诱导的认知功能障碍。
Aging (Albany NY). 2021 May 25;13(11):15240-15254. doi: 10.18632/aging.203084.
9
Non-SUMOylated CRMP2 decreases Na1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15.非 SUMO 化的 CRMP2 通过内吞蛋白 NUMB、Nedd4-2 和 Eps15 减少 Na1.7 电流。
Mol Brain. 2021 Jan 21;14(1):20. doi: 10.1186/s13041-020-00714-1.
10
Ca2.2 (N-type) voltage-gated calcium channels are activated by SUMOylation pathways.Ca2.2(N 型)电压门控钙通道通过 SUMOylation 途径激活。
Cell Calcium. 2021 Jan;93:102326. doi: 10.1016/j.ceca.2020.102326. Epub 2020 Nov 30.